NeoProgen, Inc. announced that it has received a patent from the United States Patent Office Patent No.: US 10.967,007 B2 “Cardiac Stem Cells for Cardiac Repair”.
[NeoProgen, Inc. (Business Wire, Inc.)]
1254621 nan items 1 apa default asc 1
The authors manipulated mitochondrial dynamics and found that increased mitochondrial fusion during myofibril assembly prevented mitochondrial intercalation in flight muscles.
6606345 TRULH4HK items 1 apa default asc 1
Researchers indicated that calcitonin gene-related peptide (CGRP) protected bladder smooth muscle cells from oxidative stress induced by high glucose in vitro, and inhibit the α-SM-actin expression decrease through inhibiting the intracellular p38 MAPK signaling pathway.
6606345 SNGZKHJZ items 1 apa default asc 1
Scientists identified transient receptor potential cation channel subfamily V member 1 (Trpv1)+ vascular smooth muscle cells as previously unidentified thermogenic adipocyte progenitors.
6606345 PFBZMCX4 items 1 apa default asc 1
Scientists present the most recent advances and improvements in cardiac tissue formation, including cardiomyocyte maturation and disease modeling.
Researchers investigated substrate metabolism in hiPSC-CMs grown as a monolayer and in 3D, in porous collagen-derived scaffolds and in engineered heart tissue, by measuring rates of glycolysis and glucose and fatty acid oxidation, and changes in gene expression and mitochondrial oxygen consumption.
6606345 4SMI2NHB items 1 apa default asc 1
Lopez, C. A., Al-Siddiqi, H. H. A. A., Purnama, U., Iftekhar, S., Bruyneel, A. A. N., Kerr, M., Nazir, R., da Luz Sousa Fialho, M., Malandraki-Miller, S., Alonaizan, R., Kermani, F., Heather, L. C., Czernuszka, J., & Carr, C. A. (2021). Physiological and pharmacological stimulation for in vitro maturation of substrate metabolism in human induced pluripotent stem cell-derived cardiomyocytes. Scientific Reports, 11(1), 7802. https://doi.org/10.1038/s41598-021-87186-y Cite
Biofabrication tools can be applied to engineer human three-dimensional culture systems that complement current preclinical research models. Investigators described the development of the first in vitro three-dimensional model of myotonic dystrophy type 1 human skeletal muscle.
6606345 BDR6BVIN items 1 apa default asc 1
Researchers revealed miR-129-5p as a negative regulator of myogenic differentiation and slow fiber gene expression, affecting body metabolic homeostasis.
[American Journal of Physiology-Cell Physiology]
The authors examined the regulatory effect of circular RNA HIPK3 (circHIPK3) during myocardial ischemia/reperfusion and investigated its mechanism in cardiomyocyte autophagy and apoptosis.
[Cell Death Discovery]
6606345 UU8P6YWJ items 1 apa default asc 1
Qiu, Z., Wang, Y., Liu, W., Li, C., Zhao, R., Long, X., Rong, J., Deng, W., Shen, C., Yuan, J., Chen, W., & Shi, B. (2021). CircHIPK3 regulates the autophagy and apoptosis of hypoxia/reoxygenation-stimulated cardiomyocytes via the miR-20b-5p/ATG7 axis. Cell Death Discovery, 7(1), 1–12. https://doi.org/10.1038/s41420-021-00448-6 Cite
Investigators demonstrated that long non-coding RNA(lncRNA)-FKBP1C could bound with MYH1B and enhance its protein stability, thus affecting proliferation, differentiation of myoblasts and conversion of skeletal muscle fiber types.
[Cell Death Discovery]
Scholar Rock, a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced positive top-line data from the TOPAZ Phase II clinical trial evaluating apitegromab in patients with Type 2 and Type 3 SMA.
[Scholar Rock Inc.]
6606345 nan items 1 apa default asc 1